Europe — EMA
Olmeamlodipin Puren (Olmesartan Medoxomil, Amlodipine)
GNH USA supplies Olmeamlodipin Puren (Olmesartan medoxomil & Amlodipine), a combination antihypertensive for hypertension and cardiovascular risk reduction.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxomil, the active ingredient in Olmeamlodipin Puren, is a combination antihypertensive presented as a tablet for oral use. It treats hypertension in adults, often when monotherapy does not achieve target blood pressure. GNH USA supplies Olmeamlodipin Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olmeamlodipin Puren as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmeamlodipin Puren is a fixed‑dose combination that acts on the renin‑angiotensin system and calcium‑channel pathways to lower blood pressure.
- Hypertension: helps patients reach recommended blood‑pressure targets when single‑agent therapy is insufficient. - High‑risk cardiovascular patients: contributes to overall risk reduction when combined with lifestyle measures. - Resistant hypertension: provides an additional mechanism of action for patients not controlled on other regimens.
What are the side effects of Olmesartan Medoxomil, Amlodipine?
Adverse reactions may vary in frequency and severity.
Common Side Effects: - Peripheral edema: mild swelling, usually of the ankles. - Headache: transient, often resolves with continued therapy. - Dizziness or light‑headedness: related to blood‑pressure lowering. - Flushing: brief warmth sensation. - Fatigue: general tiredness. - Nasal congestion: mild stuffiness.
Serious or Rare Side Effects: - Angio‑edema: rapid swelling of face, lips or throat requiring emergency care. - Severe hypotension: symptomatic low blood pressure, especially after dose escalation. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Acute kidney injury: sudden decline in renal function. - Myocardial infarction: rare but reported in patients with pre‑existing coronary disease. - Allergic reactions: rash, pruritus or anaphylaxis.
What precautions apply to Olmesartan Medoxomil, Amlodipine?
Before initiating therapy, consider patient‑specific factors and monitor appropriately.
- Renal impairment: adjust monitoring; use with caution in severe dysfunction. - Hepatic disease: assess liver function; use cautiously. - Electrolyte imbalance: check potassium and sodium levels regularly. - Concomitant antihypertensives: avoid excessive blood‑pressure drop. - Pregnancy: contraindicated; switch to pregnancy‑safe agents. - Breastfeeding: evaluate risk‑benefit; limited data available. - Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture and light.
What does Olmesartan Medoxomil, Amlodipine interact with?
Olmeamlodipin Puren may interact with several drug classes; clinical judgment is required.
Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyper‑kalemia. - Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): increase amlodipine levels. - Lithium: may increase lithium toxicity.
Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive effect. - Other antihypertensives (beta‑blockers, ACE inhibitors): risk of additive hypotension. - Rifampicin: may reduce amlodipine concentrations. - Alcohol: enhances vasodilatory effect, increasing dizziness. - Grapefruit juice: can raise amlodipine plasma levels.
